Log in
Enquire now
‌

US Patent 9321832 Ligand

Patent 9321832 was granted and assigned to Domantis Limited on April, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
‌
Domantis Limited
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9321832
Patent Inventor Names
Oliver Schon0
Ian Tomlinson0
Jasper Clube0
Laurent Jespers0
Lucy J. Holt0
Date of Patent
April 26, 2016
Patent Application Number
11704832
Date Filed
February 8, 2007
Patent Citations Received
‌
US Patent 12134635 Interleukin 18 (IL-18) variants and fusion proteins comprising same
0
‌
US Patent 11692032 Anti-LAG3 antibodies and uses thereof
0
‌
US Patent 12006361 Albumin binding domain fusion proteins
0
Patent Primary Examiner
‌
Hong Sang
Patent abstract

The invention provides a dual-specific ligand comprising a first immunoglobulin variable domain having a first binding specificity and a complementary or non-complementary immunoglobulin variable domain having a second binding specificity.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9321832 Ligand

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.